Veerhealth Care Q1 FY27 Results: Revenue Surges 456% to Rs 24 Crore, PAT Rises to Rs 1 Crore
- August 17, 2026
- Posted by: Neeraj Pandey
- Category: Market
Veerhealth Care Q1 FY27: Revenue Rs 24 Cr (+455.73%). PAT Rs 1 Cr (+409.81%). Gross profit Rs 1 Cr vs Rs -0.31 Cr (+592.06%). Standalone. CMP Rs 46.52 on Aug 13, 2026.
Quick Answer
Veerhealth Care Q1 FY27 results showed standalone revenue surging 455.73% to Rs 24 crore from Rs 4 crore in Q1 FY26, with gross profit swinging positive and PAT growing to Rs 1 crore — a dramatic healthcare services scale-up.
Veerhealth Care Q1 FY27 results showed the standalone healthcare company posting Rs 24 crore revenue, up 455.73% from Rs 4 crore in Q1 FY26. This dramatic revenue surge reflects either significant new hospital or clinic capacity commissioning, new diagnostic service launches, or major institutional healthcare contracts.
The Veerhealth Care Q1 FY27 results showed gross profit swinging from Rs -0.31 crore to Rs 1 crore on the revenue surge — a complete reversal of healthcare service economics from loss-making to profitable. PAT growing to Rs 1 crore from Rs 0.24 crore confirms the commercial viability of the scaled-up healthcare operations.
Click Here – Get Free Investment Predictions
Veerhealth Care Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Crore) | Q1 FY26 (Rs Crore) | YoY Change |
|---|---|---|---|
| Revenue | 24.00 | 4.00 | +455.73% |
| Gross Profit | 1.00 | -0.31 | +592.06% |
| Net Profit / PAT | 1.00 | 0.24 | +409.81% |
Veerhealth Care Q1 FY27 Performance Analysis
Use the Univest Screener to track Veerhealth Care live financials and Q1 FY27 results
Veerhealth Care Q1 FY27 results represent a dramatic healthcare services scale-up — revenue scaling 5x alongside gross profit turning positive confirms the company has crossed the healthcare capacity utilisation threshold above which operations become profitable.
Gross profit swinging from Rs -0.31 crore to Rs 1 crore in Q1 FY27 results points to the classic healthcare economics of fixed capacity: once beds, equipment, and staff are in place, additional patient volumes generate strong incremental margins.
PAT at Rs 1 crore in Q1 FY27 results, growing from Rs 0.24 crore, is modest in absolute terms on Rs 24 crore revenue — a PAT margin of 4.2%. For a healthcare company still in ramp-up phase, this is an encouraging initial profitability signal.
India’s healthcare sector — particularly secondary and tertiary hospital care — is growing rapidly driven by insurance penetration, population health awareness, and the government’s Ayushman Bharat programme extending hospitalisation access.
Key Business Factors in Q1 FY27
Healthcare Capacity Utilisation
Revenue 5x growth reflects higher patient volumes crossing the utilisation threshold where fixed healthcare capacity becomes profitable.
Service Scale-Up
New hospital capacity, diagnostic services, or institutional contracts drove the dramatic Q1 FY27 revenue surge.
Initial Profitability
Gross profit turning positive confirms the business has reached viable operational scale in Q1 FY27 results.
Dividend Details
Veerhealth Care has not declared a dividend for Q1 FY27. Healthcare expansion requires reinvestment of earnings.
FY27 Outlook
The FY27 outlook is positive with India’s healthcare demand growth. Sustaining the Rs 24 crore quarterly revenue run-rate and improving operational efficiency would deliver improving PAT margins through the year.
Key risks include patient footfall consistency, healthcare regulatory compliance, and the ability to manage healthcare delivery quality at scale.
Veerhealth Care Stock Performance
Download the Univest iOS App or Univest Android App to track Veerhealth Care share price live and stay updated on quarterly results.
Veerhealth Care shares traded at Rs 46.52 on August 13, 2026, up 6.40%, reflecting strong market enthusiasm for the dramatic Q1 FY27 results scale-up.
Key Risks
Revenue Sustainability
Rs 24 crore quarterly revenue needs to be confirmed as a stable run-rate, not a one-time exceptional quarter.
Healthcare Regulatory Risk
Healthcare services face NABH, state medical council, and insurance panel compliance requirements.
Clinical Quality Risk
Rapid scale-up in healthcare must maintain clinical quality standards — patient safety issues have severe reputational and regulatory consequences.
Conclusion
Veerhealth Care Q1 FY27 results show exceptional 456% revenue surge to Rs 24 crore and PAT growing to Rs 1 crore — a dramatic healthcare services scale-up crossing profitability thresholds.
Revenue sustainability and operational quality management are the key investment assessment points. Consult a SEBI-registered advisor.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Veerhealth Care Q1 FY27 Results
When announced?
Ans. August 13, 2026, standalone.
Revenue?
Ans. Rs 24 crore, up 455.73% from Rs 4 crore.
PAT?
Ans. Rs 1 crore, up 409.81% from Rs 0.24 crore.
What drove the 456% revenue surge?
Ans. Significant new healthcare capacity commissioning or institutional contracts driving patient volumes above the profitability threshold.
Dividend?
Ans. No dividend for Q1 FY27.
Outlook?
Ans. Positive with India’s healthcare demand. Revenue sustainability is the key monitor.
Investment?
Ans. Dramatic scale-up in healthcare. Assess revenue recurrence and clinical quality. Consult a SEBI-registered advisor.
